Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women
European Journal of Cancer · 2026-11 · 248 · 117784
DOI: 10.1016/j.ejca.2026.117784 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Davide Serrano und 23 weiteren Autor:innen. Beteiligte Einrichtung: European Institute of Oncology IRCCS, Milano, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Tamoxifen, Caloric Restriction, Antineoplastic Agents, Hormonal. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Institute of Oncology IRCCS, Milano, Italy.
- European Institute of Oncology IRCCS, Milano, Italy. Electronic address: matteo.lazzeroni@ieo.it.
- Istituto Oncologico Veneto (IOV), Padova, Italy.
- Istituto Nazionale Tumori G. Pascale, Napoli, Italy.
- E.O. Galliera - Ospedale Genova, Italy.
Förderung
- Italian Government Ministry of Health
Zitieren
APA
Serrano, D., Lazzeroni, M., Rizzo, R., Gnagnarella, P., Aurilio, G., Colombo, E., Guerrieri-Gonzaga, A., Johansson, H., Zovato, S., Nardi, M., Matteraglia, A., Pensabene, M., Buccolo, S., Pistelli, L., Giancarli, G., Carbone, A., Aristarco, V., Macis, D., Accornero, C. A., …, & Bonanni, B. (2026). Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women. European Journal of Cancer, 248, 117784. https://doi.org/10.1016/j.ejca.2026.117784
Vancouver
Serrano D, Lazzeroni M, Rizzo R, Gnagnarella P, Aurilio G, Colombo E, et al. Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women. European Journal of Cancer. 2026;248:117784. doi:10.1016/j.ejca.2026.117784
BibTeX
@article{Serrano2026,
author = {Serrano, Davide and Lazzeroni, Matteo and Rizzo, Roberta and Gnagnarella, Patrizia and Aurilio, Gaetano and Colombo, Elisa and Guerrieri-Gonzaga, Aliana and Johansson, Harriet and Zovato, Stefania and Nardi, Mariateresa and Matteraglia, Anna and Pensabene, Matilde and Buccolo, Simona and Pistelli, Luigi and Giancarli, Giorgia and Carbone, Alessio and Aristarco, Valentina and Macis, Debora and Accornero, Chiara A and Merli, Davide and Salè, Emanuela Omodeo and DeCensi, Andrea and Gandini, Sara and Bonanni, Bernardo},
title = {Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117784},
doi = {10.1016/j.ejca.2026.117784}
}
EUVIMED